Joseph Frattaroli
Nessuna posizione attualmente
Patrimonio netto: 15 229 $ in data 30/04/2024
Storia della carriera di Joseph Frattaroli
Precedenti posizioni note di Joseph Frattaroli
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Direttore Finanziario/CFO | 01/04/2018 | 31/03/2024 |
Vaso Active Pharmaceuticals, Inc.
 Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish. | Direttore Finanziario/CFO | 24/12/2009 | 06/11/2012 |
| Presidente | 01/06/2003 | 06/11/2012 | |
| Flagship Consulting, Inc. | Fondatore | 01/01/2010 | - |
Formazione di Joseph Frattaroli
| Salem State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
Posizioni
| Director of Finance/CFO | 2 |
| President | 1 |
| Founder | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INHIBIKASE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Vaso Active Pharmaceuticals, Inc.
Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish. | Health Technology |
| Flagship Consulting, Inc. |
- Borsa valori
- Insiders
- Joseph Frattaroli
- Esperienza
